News
GlobalData on MSN2mon
Lantheus acquires radiopharma CDMO Evergreen for up to $1bnUS-based radiopharmaceutical company Lantheus has announced a definitive agreement to acquire clinical-stage radiopharma ...
Holdings announced that it has completed its previously announced acquisition of Evergreen Theragnostics, a clinical-stage ...
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback